Results 221 to 230 of about 42,476 (239)

Analgesic Effect of Intraperitoneal Bupivacaine in Laparoscopic Sleeve Gastrectomy: A Matched Case-Control Study and Review of Available Data

openalex   +1 more source

Innovative Use of Atrial Septal Defect Occluders for Gastric Leak Management After Sleeve Gastrectomy: A Case Report. [PDF]

Am J Case Rep
Alsairy S, Almutairi NN.
europepmc   +1 more source

Perirenal fat area is a preoperative predictor of hypertension resolution after laparoscopic sleeve gastrectomy: Generalized additive models

Yue Li, Kai-Yuan Zheng, Zeng-Lin Liu, Tianming Yu, Wenjie Zhang, Mingwei Zhong, Sanyuan Hu   +6 more
openalex   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

FXR is a molecular target for the effects of vertical sleeve gastrectomy

Nature, 2014
Karen K Ryan, Valentina Tremaroli, Christoffer Clemmensen   +2 more
exaly  

Bariatric surgery for obesity and metabolic disorders: state of the art

Nature Reviews Gastroenterology and Hepatology, 2016
Ninh T Nguyen
exaly  

Does Sleeve Gastrectomy Expose the Distal Esophagus to Severe Reflux?

Annals of Surgery, 2020
Kai Tai Derek Yeung, Nicholas Penney, Ara Darzi   +2 more
exaly  

Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial

The Lancet Gastroenterology and Hepatology, 2020
Hitoshi Katai, Takanobu Yamada, Souya Nunobe   +2 more
exaly  

TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice

Gut, 2017
Ahmed Bettaieb, Ruth E Ley, Bethany P Cummings   +2 more
exaly  

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

Lancet, The, 2012
Yung-Jue Bang, Young-Woo Kim, Han-Kwang Yang   +2 more
exaly  

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

Lancet Oncology, The, 2014
Sung Hoon Noh, Sook Ryun Park, Han-Kwang Yang   +2 more
exaly